Annual D&A
$7.82 M
-$5.21 M-40.02%
31 December 2023
Summary:
Nektar Therapeutics annual depreciation & amortization is currently $7.82 million, with the most recent change of -$5.21 million (-40.02%) on 31 December 2023. During the last 3 years, it has fallen by -$6.37 million (-44.89%). NKTR annual D&A is now -80.65% below its all-time high of $40.38 million, reached on 31 December 2001.NKTR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$993.00 K
-$466.00 K-31.94%
30 September 2024
Summary:
Nektar Therapeutics quarterly depreciation & amortization is currently $993.00 thousand, with the most recent change of -$466.00 thousand (-31.94%) on 30 September 2024. Over the past year, it has dropped by -$702.00 thousand (-41.42%). NKTR quarterly D&A is now -89.79% below its all-time high of $9.72 million, reached on 30 June 2006.NKTR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$5.71 M
-$702.00 K-10.95%
30 September 2024
Summary:
Nektar Therapeutics TTM depreciation & amortization is currently $5.71 million, with the most recent change of -$702.00 thousand (-10.95%) on 30 September 2024. Over the past year, it has dropped by -$3.63 million (-38.89%). NKTR TTM D&A is now -82.96% below its all-time high of $33.51 million, reached on 31 December 2006.NKTR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.0% | -41.4% | -38.9% |
| 3 y3 years | -44.9% | -72.6% | -59.1% |
| 5 y5 years | -28.1% | -71.2% | -54.9% |
NKTR Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -44.9% | at low | -73.4% | at low | -60.1% | at low |
| 5 y | 5 years | -44.9% | at low | -77.9% | at low | -61.2% | at low |
| alltime | all time | -80.7% | +1463.0% | -89.8% | at low | -83.0% | +20.7% |
Nektar Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $993.00 K(-31.9%) | $5.71 M(-10.9%) |
| June 2024 | - | $1.46 M(-9.2%) | $6.41 M(-9.9%) |
| Mar 2024 | - | $1.61 M(-2.7%) | $7.12 M(-8.9%) |
| Dec 2023 | $7.82 M(-40.0%) | $1.65 M(-2.5%) | $7.82 M(-16.4%) |
| Sept 2023 | - | $1.70 M(-21.7%) | $9.35 M(-9.5%) |
| June 2023 | - | $2.17 M(-5.9%) | $10.33 M(-11.0%) |
| Mar 2023 | - | $2.30 M(-27.7%) | $11.60 M(-11.0%) |
| Dec 2022 | $13.03 M(-7.9%) | $3.18 M(+18.9%) | $13.03 M(-1.9%) |
| Sept 2022 | - | $2.68 M(-22.2%) | $13.28 M(-6.6%) |
| June 2022 | - | $3.44 M(-7.7%) | $14.23 M(-0.7%) |
| Mar 2022 | - | $3.73 M(+8.6%) | $14.33 M(+1.3%) |
| Dec 2021 | $14.15 M(-0.3%) | $3.44 M(-5.1%) | $14.15 M(+1.4%) |
| Sept 2021 | - | $3.62 M(+2.1%) | $13.96 M(+2.8%) |
| June 2021 | - | $3.55 M(+0.1%) | $13.58 M(+2.7%) |
| Mar 2021 | - | $3.54 M(+9.2%) | $13.22 M(-6.8%) |
| Dec 2020 | $14.18 M(+7.8%) | $3.25 M(0.0%) | $14.18 M(-2.3%) |
| Sept 2020 | - | $3.25 M(+1.7%) | $14.51 M(-1.4%) |
| June 2020 | - | $3.19 M(-29.1%) | $14.72 M(+0.9%) |
| Mar 2020 | - | $4.50 M(+26.0%) | $14.58 M(+10.8%) |
| Dec 2019 | $13.16 M(+21.0%) | $3.57 M(+3.6%) | $13.16 M(+4.0%) |
| Sept 2019 | - | $3.45 M(+12.9%) | $12.65 M(+6.4%) |
| June 2019 | - | $3.06 M(-0.7%) | $11.89 M(+4.2%) |
| Mar 2019 | - | $3.08 M(+0.2%) | $11.41 M(+4.9%) |
| Dec 2018 | $10.87 M(-26.3%) | $3.07 M(+14.4%) | $10.87 M(+3.9%) |
| Sept 2018 | - | $2.68 M(+4.3%) | $10.46 M(-9.6%) |
| June 2018 | - | $2.57 M(+1.3%) | $11.57 M(-12.7%) |
| Mar 2018 | - | $2.54 M(-4.5%) | $13.25 M(-10.1%) |
| Dec 2017 | $14.74 M(-4.0%) | $2.66 M(-29.9%) | $14.74 M(-7.5%) |
| Sept 2017 | - | $3.79 M(-10.8%) | $15.93 M(-0.5%) |
| June 2017 | - | $4.25 M(+5.5%) | $16.00 M(+2.1%) |
| Mar 2017 | - | $4.03 M(+4.8%) | $15.67 M(+2.1%) |
| Dec 2016 | $15.35 M(+19.4%) | $3.85 M(-0.5%) | $15.35 M(+0.7%) |
| Sept 2016 | - | $3.87 M(-1.3%) | $15.25 M(+4.0%) |
| June 2016 | - | $3.92 M(+5.5%) | $14.66 M(+7.8%) |
| Mar 2016 | - | $3.71 M(-0.8%) | $13.60 M(+5.8%) |
| Dec 2015 | $12.86 M(-0.6%) | $3.75 M(+14.3%) | $12.86 M(+4.5%) |
| Sept 2015 | - | $3.28 M(+14.5%) | $12.30 M(+0.5%) |
| June 2015 | - | $2.86 M(-3.8%) | $12.24 M(-3.1%) |
| Mar 2015 | - | $2.97 M(-6.9%) | $12.64 M(-2.3%) |
| Dec 2014 | $12.93 M(-9.4%) | $3.19 M(-0.6%) | $12.93 M(-1.5%) |
| Sept 2014 | - | $3.21 M(-1.3%) | $13.13 M(-2.9%) |
| June 2014 | - | $3.25 M(-0.3%) | $13.51 M(-2.9%) |
| Mar 2014 | - | $3.26 M(-3.8%) | $13.91 M(-2.5%) |
| Dec 2013 | $14.28 M(-1.6%) | $3.39 M(-5.8%) | $14.28 M(-2.1%) |
| Sept 2013 | - | $3.60 M(-1.4%) | $14.58 M(-1.7%) |
| June 2013 | - | $3.65 M(+0.7%) | $14.84 M(+1.4%) |
| Mar 2013 | - | $3.63 M(-1.9%) | $14.63 M(+0.8%) |
| Dec 2012 | $14.51 M | $3.70 M(-4.1%) | $14.51 M(+1.2%) |
| Sept 2012 | - | $3.86 M(+12.1%) | $14.34 M(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $3.44 M(-1.9%) | $14.25 M(-2.4%) |
| Mar 2012 | - | $3.51 M(-0.5%) | $14.61 M(-2.3%) |
| Dec 2011 | $14.95 M(-9.7%) | $3.53 M(-6.6%) | $14.95 M(-3.4%) |
| Sept 2011 | - | $3.77 M(-0.5%) | $15.48 M(-2.5%) |
| June 2011 | - | $3.79 M(-1.6%) | $15.87 M(-2.4%) |
| Mar 2011 | - | $3.86 M(-4.8%) | $16.26 M(-1.8%) |
| Dec 2010 | $16.55 M(+11.2%) | $4.05 M(-2.7%) | $16.55 M(+1.5%) |
| Sept 2010 | - | $4.17 M(-0.5%) | $16.30 M(+2.8%) |
| June 2010 | - | $4.18 M(+0.9%) | $15.86 M(+2.9%) |
| Mar 2010 | - | $4.15 M(+9.0%) | $15.41 M(+3.6%) |
| Dec 2009 | $14.88 M(-33.8%) | $3.81 M(+2.4%) | $14.88 M(-4.7%) |
| Sept 2009 | - | $3.72 M(-0.7%) | $15.61 M(-15.5%) |
| June 2009 | - | $3.74 M(+3.6%) | $18.46 M(-9.5%) |
| Mar 2009 | - | $3.62 M(-20.3%) | $20.41 M(-9.3%) |
| Dec 2008 | $22.49 M(-22.5%) | $4.54 M(-31.0%) | $22.49 M(-8.9%) |
| Sept 2008 | - | $6.57 M(+15.6%) | $24.67 M(-3.6%) |
| June 2008 | - | $5.68 M(-0.2%) | $25.60 M(-6.5%) |
| Mar 2008 | - | $5.70 M(-15.2%) | $27.37 M(-5.7%) |
| Dec 2007 | $29.03 M(-13.4%) | $6.72 M(-10.3%) | $29.03 M(-5.7%) |
| Sept 2007 | - | $7.50 M(+0.5%) | $30.77 M(+1.9%) |
| June 2007 | - | $7.46 M(+1.5%) | $30.21 M(-7.0%) |
| Mar 2007 | - | $7.35 M(-13.1%) | $32.47 M(-3.1%) |
| Dec 2006 | $33.51 M(+27.7%) | $8.46 M(+22.1%) | $33.51 M(+0.8%) |
| Sept 2006 | - | $6.93 M(-28.7%) | $33.24 M(+2.0%) |
| June 2006 | - | $9.72 M(+15.9%) | $32.59 M(+12.3%) |
| Mar 2006 | - | $8.39 M(+2.4%) | $29.01 M(+10.6%) |
| Dec 2005 | $26.23 M(+36.7%) | $8.19 M(+30.5%) | $26.23 M(+11.5%) |
| Sept 2005 | - | $6.28 M(+2.1%) | $23.54 M(+8.4%) |
| June 2005 | - | $6.15 M(+9.6%) | $21.72 M(+7.2%) |
| Mar 2005 | - | $5.61 M(+2.0%) | $20.26 M(+5.6%) |
| Dec 2004 | $19.19 M(+4.2%) | $5.50 M(+23.2%) | $19.19 M(+4.7%) |
| Sept 2004 | - | $4.46 M(-4.9%) | $18.32 M(+0.3%) |
| June 2004 | - | $4.69 M(+3.4%) | $18.27 M(-0.6%) |
| Mar 2004 | - | $4.54 M(-2.1%) | $18.38 M(-0.2%) |
| Dec 2003 | $18.42 M(-2.9%) | $4.63 M(+5.0%) | $18.42 M(+0.7%) |
| Sept 2003 | - | $4.41 M(-8.1%) | $18.29 M(-3.7%) |
| June 2003 | - | $4.80 M(+5.0%) | $19.00 M(+1.0%) |
| Mar 2003 | - | $4.57 M(+1.4%) | $18.81 M(-0.8%) |
| Dec 2002 | $18.97 M(-53.0%) | $4.51 M(-12.0%) | $18.97 M(+31.2%) |
| Sept 2002 | - | $5.12 M(+11.1%) | $14.46 M(+54.8%) |
| June 2002 | - | $4.61 M(-2.5%) | $9.34 M(+97.5%) |
| Mar 2002 | - | $4.73 M | $4.73 M |
| Dec 2001 | $40.38 M(+298.9%) | - | - |
| Dec 2000 | $10.12 M(+39.6%) | - | - |
| Dec 1999 | $7.25 M(+101.6%) | - | - |
| Dec 1998 | $3.60 M(+47.6%) | - | - |
| Dec 1997 | $2.44 M(+103.2%) | - | - |
| Dec 1996 | $1.20 M(+9.1%) | - | - |
| Dec 1995 | $1.10 M(+120.0%) | - | - |
| Dec 1994 | $500.00 K | - | - |
FAQ
- What is Nektar Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Nektar Therapeutics?
- What is Nektar Therapeutics annual D&A year-on-year change?
- What is Nektar Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly D&A year-on-year change?
- What is Nektar Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Nektar Therapeutics?
- What is Nektar Therapeutics TTM D&A year-on-year change?
What is Nektar Therapeutics annual depreciation & amortization?
The current annual D&A of NKTR is $7.82 M
What is the all time high annual D&A for Nektar Therapeutics?
Nektar Therapeutics all-time high annual depreciation & amortization is $40.38 M
What is Nektar Therapeutics annual D&A year-on-year change?
Over the past year, NKTR annual depreciation & amortization has changed by -$5.21 M (-40.02%)
What is Nektar Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of NKTR is $993.00 K
What is the all time high quarterly D&A for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly depreciation & amortization is $9.72 M
What is Nektar Therapeutics quarterly D&A year-on-year change?
Over the past year, NKTR quarterly depreciation & amortization has changed by -$702.00 K (-41.42%)
What is Nektar Therapeutics TTM depreciation & amortization?
The current TTM D&A of NKTR is $5.71 M
What is the all time high TTM D&A for Nektar Therapeutics?
Nektar Therapeutics all-time high TTM depreciation & amortization is $33.51 M
What is Nektar Therapeutics TTM D&A year-on-year change?
Over the past year, NKTR TTM depreciation & amortization has changed by -$3.63 M (-38.89%)